Aurora Biomed Inc. is pleased to announce that it has signed an agreement with Alion Pharmaceuticals and Specs to form a new Ion Channel Consortium that will provide a novel, comprehensive solution for ion channel drug discovery.
Next generation sequencing (NGS) technologies are emerging as a powerful means for providing gigabases of genetic information. Increased throughput and reduced sequencing costs have revolutionized genomics research.
Several methods are available to assess vitamin D sufficiency through measurement of serum 25-hydroxy vitamin D [25(OH)D]. Antibody (ELISA) or other protein-binding assays are available, but may not accurately report total vitamin D values. Moreover, manual sample preparation methods for assays such as LC-MS/MS or HPLC are very cumbersome.
Aurora is pleased to announce the launch of its new VERSATM Cap Piercing Workstation. This fully automated, multi-tasking robotic system is programmed to perform closed tube sampling (CTS), automate sample transfer, dilution and much more. Using this workstation simplifies tedious, repetitive and error prone sample preparation protocols.
Aurora is pleased to announce the launch of our VERSA Vial Filling Workstation. The VERSA Vial Filling workstation is a compact, fully automated robotic system capable of consistently dispensing accurate volumes. It turns the tedious, time-consuming, error prone and repetitive process of filling reagents into a practical and satisfactory one.